Home » Chemicals » Semi-Solid Dosage Forms Contract Manufacturing Market

Semi-Solid Dosage Forms Contract Manufacturing Market By Type (Creams, Gels, Ointments, Pastes, Suppositories); By Application (Antibiotic, Antifungal, Antiseptic, Corticosteroid); By End User (Pharmaceutical Companies, Biopharmaceutical Companies, Contract Manufacturing Organizations); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4999

Published: | Report ID: 33462 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period  2019-2022
Base Year  2023
Forecast Period  2024-2032
Semi-Solid Dosage Forms Contract Manufacturing Market Size Size 2023  USD 13,569.19 Million
Semi-Solid Dosage Forms Contract Manufacturing Market Size, CAGR  5.40%
Semi-Solid Dosage Forms Contract Manufacturing Market Size Size 2032  USD 21,913.76 Million

Market Overview

The global demand for the Semi Solid Dosage Forms Contract Manufacturing Market was valued at USD 13,569.19 Million in 2023 is expected to reach USD 21,913.76 Million in 2032 growing at a CAGR of 5.40% between 2024 and 2032.

The Semi-Solid Dosage Forms Contract Manufacturing Market is experiencing significant growth, primarily due to the increasing demand for pharmaceutical products that are easier to administer and exhibit enhanced efficacy with reduced side effects. Semi-solid dosage forms, including creams, gels, ointments, and pastes, have become increasingly popular in various therapeutic areas such as dermatology, analgesics, and anti-infectives. This market’s expansion is underpinned by the pharmaceutical industry’s ongoing efforts to improve drug delivery systems, enhancing patient compliance and therapeutic outcomes.

Contract manufacturing in the semi-solid dosage form sector is driven by the need for pharmaceutical companies to leverage specialized manufacturing capabilities, comply with regulatory standards, and reduce costs associated with in-house production facilities. The global market value is on the rise, with projections indicating a continued upward trajectory fueled by the growing prevalence of skin diseases, chronic pain conditions, and the need for novel drug delivery mechanisms.

The collaboration between pharmaceutical companies and contract manufacturers facilitates the efficient production of semi-solid dosage forms, enabling faster market entry of new drugs and the optimization of existing formulations. The strategic outsourcing to contract manufacturers not only helps in navigating complex regulatory landscapes but also in accessing advanced manufacturing technologies and expertise in formulation development.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Key Market Drivers

Increasing Demand for Specialized Formulations

The pharmaceutical industry’s push towards more patient-centric treatments has led to a heightened demand for specialized formulations. Semi-solid dosage forms, such as creams, ointments, gels, and suppositories, are increasingly preferred for their ease of application, targeted delivery, and enhanced patient compliance. This shift towards specialized formulations is driving pharmaceutical companies to seek out contract manufacturing organizations (CMOs) that possess the expertise and capabilities to develop and manufacture these complex products. As a result, CMOs specializing in semi-solid forms are experiencing a surge in demand for their services.

Cost-Effective Solutions

Cost pressures within the pharmaceutical industry continue to escalate, prompting companies to look for ways to reduce expenses across the board. Outsourcing manufacturing to CMOs presents an attractive cost-effective solution, particularly for semi-solid dosage forms. By leveraging the specialized infrastructure and economies of scale offered by CMOs, pharmaceutical firms can significantly lower their production costs. This outsourcing not only helps manage budgets more effectively but also allows companies to allocate more resources towards research and development, ultimately enhancing their competitive edge in the market.

Reduced Time-to-Market

In today’s fast-paced pharmaceutical environment, speed is of the essence. Companies are under constant pressure to accelerate their drug development processes and reduce the time-to-market for new therapies. Partnering with CMOs for the manufacturing of semi-solid dosage forms can streamline production timelines through efficient, scalable processes and expert project management. This collaboration ensures that pharmaceutical products reach the market quicker, providing patients with timely access to new treatments. The ability of CMOs to expedite the production process without compromising on quality is a critical factor driving their increased utilization in the semi-solid dosage form sector.

Enhanced Patient Compliance Spurs Demand

A key factor propelling the growth of this market is the increasing demand for dosage forms that enhance patient compliance. Semi-solid forms, such as softgels and chewables, offer superior ease of swallowing when compared to conventional solid dosage forms like tablets and capsules. This attribute is especially advantageous for pediatric and geriatric patient groups, who often face difficulties in swallowing pills. Consequently, semi-solid dosage forms lead to higher patient compliance and adherence to prescribed medication schedules.

Technological Innovations Boost Production

Technological advancements, particularly in hot-melt extrusion (HME) technology, are revolutionizing the production of complex semi-solid formulations. HME technology facilitates the efficient and cost-effective integration of drugs with poor water solubility into a suitable carrier matrix, thereby enhancing their bioavailability. This technological progress is a significant driver in the market’s expansion.

Novel Drug Delivery Systems Gain Popularity

The market is also witnessing a surge in the popularity of novel drug delivery systems. Semi-solid dosage forms are at the forefront, offering mechanisms for controlled and sustained drug release. This feature is particularly beneficial for managing chronic conditions, which necessitate long-term treatment, by improving therapeutic efficacy and minimizing the frequency of dosing.

Outsourcing Trends Propel Market Growth

Outsourcing of non-core activities, including manufacturing, to contract manufacturing organizations (CMOs) is a growing trend within the pharmaceutical industry. Driven by the need for cost optimization, access to specialized expertise, and enhanced operational efficiency, pharmaceutical companies are increasingly leveraging CMOs for the production of semi-solid dosage forms. This outsourcing trend is a critical driver for market expansion.

Demand for Bioavailability Enhancement

Lastly, the growing need to enhance the bioavailability of poorly soluble drugs is fueling market growth. Semi-solid formulations, through the use of lipid-based carriers, offer a viable solution to improve the bioavailability of biopharmaceutical drugs that exhibit limited oral bioavailability. This demand for bioavailability enhancement underscores the importance of semi-solid dosage forms in the pharmaceutical manufacturing sector.

Key Market Restraints

While the semi-solid dosage forms contract manufacturing market is on a growth trajectory, it encounters several significant challenges that could impede its progress.

Quality and Regulatory Compliance Challenges

Ensuring quality and adhering to stringent regulatory standards are paramount in the pharmaceutical industry, especially for semi-solid dosage forms like gels, creams, and ointments. The complexity of these formulations requires sophisticated manufacturing processes and rigorous testing to meet the safety and efficacy standards set by regulatory bodies such as the FDA and EMA. Contract manufacturing organizations (CMOs) must navigate these regulatory landscapes, which can vary significantly across different regions, adding layers of complexity to compliance efforts. The high costs and operational demands associated with maintaining compliance can pose significant challenges, particularly for smaller CMOs with limited resources.

Fragmented Nature of the Industry

The semi-solid dosage form contract manufacturing market is characterized by its fragmented nature, with numerous players ranging from large multinational corporations to smaller, specialized firms. This fragmentation can lead to increased competition and pressure on pricing, making it difficult for companies to maintain profitability and invest in necessary technological advancements. Additionally, the diversity of capabilities and focus areas among CMOs can make it challenging for pharmaceutical companies to find partners that precisely match their specific needs, potentially leading to inefficiencies and delays in product development and manufacturing.

Risk of Technology Obsolescence

The pharmaceutical manufacturing sector is rapidly evolving, with continuous advancements in technology and manufacturing processes. For CMOs specializing in semi-solid dosage forms, staying ahead of technological developments is crucial to remain competitive and meet the increasingly complex demands of pharmaceutical companies. However, the risk of technology obsolescence is a significant restraint, as investing in new technologies requires substantial capital and resources. CMOs that fail to keep pace with technological advancements may find themselves at a competitive disadvantage, unable to offer the innovative solutions and efficiencies demanded by the market.

Stringent Regulatory Landscape

One of the foremost challenges is navigating the stringent regulatory environment established by authorities such as the FDA and EMA. These regulatory frameworks, designed to ensure the safety, efficacy, and quality of pharmaceutical products, impose complex, time-intensive, and costly compliance requirements on contract manufacturers. Adhering to these guidelines, while essential, presents a considerable challenge, particularly for smaller or less experienced contract manufacturing organizations (CMOs).

Volatility in Raw Material Costs

The cost of raw materials essential for semi-solid formulations, such as lipids and excipients, is subject to volatility and price fluctuations. These variations can affect the profitability of contract manufacturers, potentially leading to instability in the pricing of finished products and impacting the overall competitiveness of CMOs.

Despite these challenges, the semi-solid dosage forms contract manufacturing market holds considerable potential. With ongoing technological innovations, a rising demand for patient-centric pharmaceutical solutions, and strategic collaborations between pharmaceutical firms and CMOs, the market can navigate these obstacles. Embracing these strategies can unlock new growth avenues and ensure the continued expansion of this niche yet vital segment of the pharmaceutical industry.

Market Opportunities

  1. Expansion into Emerging Markets: Emerging economies present significant opportunities for contract manufacturers to expand their footprint, driven by growing healthcare expenditures, increasing access to healthcare, and a rising prevalence of chronic diseases.
  2. Innovation in Drug Delivery Systems: There is a continuous need for innovative drug delivery systems that enhance patient compliance and efficacy. Contract manufacturers that invest in R&D capabilities to develop novel semi-solid formulations will find new growth avenues.
  3. Collaborations with Biotech and Pharmaceutical Companies: Strategic partnerships with biotech and pharmaceutical companies for the development and manufacturing of semi-solid dosage forms can open up new opportunities.
  4. Technological Advancements in Manufacturing Processes: Implementing advanced manufacturing technologies, such as continuous manufacturing and automation, can improve efficiency, reduce costs, and attract more clients.
  5. Focus on Niche Therapeutic Areas: Specializing in semi-solid dosage forms for niche therapeutic areas, such as rare dermatological conditions or targeted pain management, can differentiate contract manufacturers in the market.
  6. Regulatory Expertise: Offering comprehensive regulatory services, including support for regulatory submissions and compliance, can provide a competitive edge and facilitate market entry for pharmaceutical clients.
  7. Sustainability Practices: Incorporating sustainable manufacturing practices can appeal to environmentally conscious clients and contribute to corporate social responsibility goals.

Interesting Facts About the Market

  1. The market for semi-solid dosage forms is one of the fastest-growing segments in the pharmaceutical contract manufacturing industry.
  2. Topical medications account for a significant share of the dermatology market, highlighting the importance of semi-solid formulations.
  3. Advanced technologies, such as 3D printing, are being explored for the manufacturing of semi-solid dosage forms, offering potential for personalized medicine.
  4. Contract manufacturers are increasingly adopting Quality by Design (QbD) approaches to enhance product quality and manufacturing efficiency.
  5. The COVID-19 pandemic has underscored the importance of flexible and resilient supply chains, with contract manufacturers playing a critical role in ensuring drug supply continuity.
  6. There is a growing trend towards the use of natural and plant-based ingredients in semi-solid formulations, driven by consumer demand for “cleaner” pharmaceutical products.
  7. The use of artificial intelligence and machine learning in formulation development is gaining traction, potentially reducing development time and improving formulation efficacy.
  8. Patent expirations of blockbuster drugs are prompting pharmaceutical companies to explore semi-solid formulations for lifecycle management strategies.
  9. Regulatory agencies are increasingly focusing on the manufacturing quality and safety of semi-solid dosage forms, leading to more rigorous inspections and compliance requirements.
  10. The market is witnessing a surge in demand for generic topical medications, presenting opportunities for contract manufacturers with expertise in semi-solid formulations.

Top Leading Players

The market is characterized by the presence of several key players who specialize in the contract manufacturing of semi-solid dosage forms. These companies offer a range of services from formulation development to large-scale production and packaging. They are known for their regulatory expertise, advanced manufacturing facilities, and commitment to quality. Collaboration with these leaders enables pharmaceutical companies to efficiently bring their products to market while adhering to stringent regulatory standards.

  • AbbVie Inc.
  • Aenova Group
  • Catalent, Inc.
  • Lonza
  • Piramal Enterprises Ltd.
  • Recipharm AB
  • Thermo Fisher Scientific
  • Almac Group
  • Ascendia Pharmaceuticals
  • Ciron Drugs & Pharmaceuticals Pvt. Ltd.
  • Fareva
  • Granules India Limited
  • Medical Products Laboratories, Inc.
  • NextPharma
  • Pfizer CentreOne

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Competitive Landscape

The competitive landscape of the Semi-Solid Dosage Forms Contract Manufacturing Market is marked by intense competition among contract manufacturers aiming to offer differentiated services. Companies compete on factors such as manufacturing capabilities, technological expertise, quality assurance, regulatory compliance, and cost-effectiveness. Strategic partnerships, mergers, and acquisitions are common strategies employed by companies to enhance their service offerings and expand their global reach.

Regional Analysis

North America Dominates the Market

North America is anticipated to maintain the largest share of the global semi-solid dosage form contract manufacturing market, with the United States playing a pivotal role. This dominance is attributed to substantial research and development expenditures by pharmaceutical companies and a growing demand for specialized manufacturing services. In 2022, the US contract manufacturing market captured over 40% of the global market share, bolstered by the presence of leading contract manufacturing organizations (CMOs) such as Catalent, Thermo Fisher Scientific, and Lonza Group. This strong market position is driven by advanced manufacturing capabilities and a robust pharmaceutical industry.

Europe

Europe stands as the second-largest market, driven by substantial investments in biopharmaceutical research and an increasing trend of outsourcing manufacturing services. Germany, Switzerland, Italy, and France are notable for their significant contract manufacturing capacities, serving the needs of European pharmaceutical companies. The region accounted for around 30% of the global market share in 2022, showcasing its critical role in the semi-solid dosage form contract manufacturing landscape.

Asia Pacific

The Asia Pacific region is poised for the fastest growth in the coming years, fueled by rising investments in research and development and an expansion in generic drug manufacturing. China and India are at the forefront, collectively holding approximately 15% of the market share in 2022. The region’s competitive advantages include lower operating costs, a skilled workforce, and supportive government policies, making it an attractive hub for outsourcing manufacturing services.

Rest of the World: Emerging Market with Steady Growth

Although smaller in comparison, the Rest of the World (RoW) segment is expected to experience steady growth. Factors contributing to this upward trend include rising healthcare investments and the development of pharmaceutical manufacturing sectors. In 2022, the RoW market contributed to 5-10% of the global market share, with Brazil, Saudi Arabia, Argentina, and South Africa identified as key emerging markets. These regions are gradually establishing themselves as significant players in the global semi-solid dosage form contract manufacturing market, driven by evolving healthcare infrastructures and market dynamics.

Future Outlook

  1. Increased Focus on Personalized Medicine: The demand for personalized semi-solid dosage forms is expected to rise, driven by advancements in precision medicine.
  2. Adoption of Sustainable Manufacturing Practices: Sustainability will become a key focus area, with more contract manufacturers adopting green practices.
  3. Expansion into New Therapeutic Areas: Contract manufacturers will explore semi-solid formulations for new therapeutic areas beyond dermatology, such as oncology and neurology.
  4. Integration of Digital Technologies: Digital transformation, including the use of AI, IoT, and blockchain, will streamline manufacturing processes and supply chain management.
  5. Emphasis on Patient-Centric Formulations: The development of patient-friendly semi-solid dosage forms that enhance compliance and efficacy will gain prominence.
  6. Regulatory Harmonization: Efforts towards regulatory harmonization will facilitate smoother market access for semi-solid dosage forms across regions.
  7. Advanced Drug Delivery Technologies: Investment in advanced drug delivery technologies will enable the development of more effective and targeted semi-solid formulations.
  8. Growth in Generic and OTC Markets: The generic and over-the-counter (OTC) markets will provide new opportunities for contract manufacturers.
  9. Collaborative Ecosystems: The formation of collaborative ecosystems involving pharmaceutical companies, contract manufacturers, and technology providers will accelerate innovation.
  10. Global Expansion: Contract manufacturers will continue to expand their global presence, particularly in emerging markets, to tap into new customer bases and cost advantages.

The Semi-Solid Dosage Forms Contract Manufacturing Market is poised for sustained growth, driven by technological advancements, evolving healthcare needs, and the strategic outsourcing by pharmaceutical companies. As the market continues to evolve, contract manufacturers that innovate, adapt to regulatory changes, and focus on quality and efficiency will be well-positioned to seize the opportunities presented by this dynamic industry.

Table of Content

Chapter No. 1 :  Introduction   44

1.1.        Report Description   44

1.1.1.     Purpose of the Report  44

1.1.2.     USP & Key Offerings  44

1.2.        Key Benefits for Stakeholders  44

1.3.        Target Audience  45

1.4.        Report Scope  46

Chapter No. 2 :  Executive Summary  48

2.1.        Semi Solid Dosage Forms Contract Manufacturing Market Snapshot  48

2.2.        Global Semi Solid Dosage Forms Contract Manufacturing Market, 2018 – 2032 (USD Million)  49

Chapter No. 3 :  Geopolitical Crisis Impact Analysis  50

3.1.        Russia-Ukraine and Israel-Palestine War Impacts  50

3.1.1.     Logistic Challenges  50

3.1.2.     Supply chain disruptions  50

3.1.3.     Regulatory Implications  50

3.1.4.     Market Instability  50

3.1.5.     Risk Management  50

3.1.6.     Global Collaboration and Partnerships  50

Chapter No. 4 :  Semi Solid Dosage Forms Contract Manufacturing Market – Industry Analysis  51

4.1.        Introduction   51

4.2.        Market Drivers  52

4.2.1.     Increasing Demand for Specialized Formulations  52

4.2.2.     Cost-Effective Solutions  52

4.2.3.     Reduced Time-to-Market  53

4.3.        Market Restraints  55

4.3.1.     Quality and Regulatory Compliance Challenges  55

4.3.2.     Fragmented Nature of the Industry  56

4.3.3.     Risk of Technology Obsolescence  56

4.4.        Market Opportunities  57

4.4.1.     Outsourcing Complex Manufacturing Processes  57

4.4.2.     Globalization of Pharmaceutical Supply Chains  57

4.5.        Porter’s Five Forces Analysis  59

4.6.        Value Chain Analysis  61

Chapter No. 5 :  Competitive Landscape Analysis  62

5.1.        Company Market Share Analysis – 2023  62

5.1.1.     Global Semi Solid Dosage Forms Contract Manufacturing Market: Company Market Share, by Revenue, 2023  62

5.1.2.     Global Semi Solid Dosage Forms Contract Manufacturing Market: Top 6 Company Market Share, by Revenue, 2023  63

5.1.3.     Global Semi Solid Dosage Forms Contract Manufacturing Market: Top 3 Company Market Share, by Revenue, 2023  64

5.1.        Global Semi Solid Dosage Forms Contract Manufacturing Market Company Revenue Market Share, 2023  65

5.2.        Company Assessment Metrics, 2023  66

5.2.1.     Stars  66

5.2.2.     Emerging Leaders  66

5.2.3.     Pervasive Players  66

5.2.4.     Participants  66

5.3.        Strategic Developments  67

5.3.1.     Acquisitions & Mergers, Partnership, Expansion, etc. 67

5.4.        Key Players Product Matrix  70

Chapter No. 6 :  PESTEL & Adjacent Market Analysis  75

6.1.        PESTEL  75

6.1.1.     Political Factors  75

6.1.2.     Economic Factors  75

6.1.3.     Social Factors  75

6.1.4.     Technological Factors  75

6.1.5.     Environmental Factors  76

6.1.6.     Legal Factors  76

6.2.        Adjacent Market Analysis  77

Chapter No. 7 :  Semi Solid Dosage Forms Contract Manufacturing Market – By Type Segment Analysis  79

7.1.        Semi Solid Dosage Forms Contract Manufacturing Market Overview, by Type Segment  79

7.1.1.     Key Types  79

7.1.2.     Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032  80

7.1.3.     Semi Solid Dosage Forms Contract Manufacturing Market Attractiveness Analysis, By Type  81

7.1.4.     Incremental Revenue Growth Opportunity, by Type, 2024 – 2032  82

7.1.5.     Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032  83

7.2.        Creams  84

7.2.1.     Global Creams Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 85

7.3.        Ointments  86

7.3.1.     Global Ointments Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 87

7.3.2.     Global Ointments Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 87

7.4.        Pastes  88

7.4.1.     Global Pastes Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 89

7.4.2.     Global Pastes Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 89

7.5.        Gels  90

7.5.1.     Global Gels Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 91

7.5.2.     Global Gels Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 91

7.6.        Others  92

7.6.1.     Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 93

Chapter No. 8 :  Semi Solid Dosage Forms Contract Manufacturing Market – By Application Segment Analysis  94

8.1.        Semi Solid Dosage Forms Contract Manufacturing Market Overview, by Application Segment  94

8.1.1.     Key Application Segments  94

8.1.2.     Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Application, 2023 & 2032  95

8.1.3.     Semi Solid Dosage Forms Contract Manufacturing Market Attractiveness Analysis, By Application  96

8.1.4.     Incremental Revenue Growth Opportunity, by Application, 2024 – 2032  97

8.1.5.     Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018, 2023, 2027 & 2032  98

8.2.        Drug Product Development  99

8.2.1.     Global Drug Product Development Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 100

8.2.2.     Global Drug Product Development Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 100

8.3.        Fill-Finish Product Manufacturing  101

8.3.1.     Global Fill-Finish Product Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 102

8.3.2.     Global Fill-Finish Product Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 102

8.4.        API Manufacturing  103

8.4.1.     Global API Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 104

8.4.2.     Global API Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 104

8.5.        Packaging/Labelling  105

8.5.1.     Global Packaging/Labelling Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 106

8.5.2.     Global Packaging/Labelling Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 106

8.6.        Others  107

8.6.1.     Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 108

8.6.2.     Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 108

Chapter No. 9 :  Semi Solid Dosage Forms Contract Manufacturing Market – By Therapeutic Area Segment Analysis  109

9.1.        Semi Solid Dosage Forms Contract Manufacturing Market Overview, by Therapeutic Area Segment  109

9.1.1.     Key Therapeutic Area Segments  109

9.1.2.     Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032  110

9.1.3.     Semi Solid Dosage Forms Contract Manufacturing Market Attractiveness Analysis, By Therapeutic Area  111

9.1.4.     Incremental Revenue Growth Opportunity, by Therapeutic Area, 2024 – 2032  112

9.1.5.     Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032  113

9.2.        Dermatological Applications  114

9.2.1.     Global Dermatological Applications Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 115

9.2.2.     Global Dermatological Applications Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 115

9.3.        Topical Analgesics  116

9.3.1.     Global Topical Analgesics Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 117

9.3.2.     Global Topical Analgesics Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 117

9.4.        Skincare Products  118

9.4.1.     Global Skincare Products Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 119

9.4.2.     Global Skincare Products Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 119

9.5.        Wound Healing  120

9.5.1.     Global Wound Healing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 121

9.5.2.     Global Wound Healing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 121

9.6.        Others  122

9.6.1.     Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 123

9.6.2.     Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 123

Chapter No. 10 :              Semi Solid Dosage Forms Contract Manufacturing Market – Regional Analysis  124

10.1.      Semi Solid Dosage Forms Contract Manufacturing Market Overview, by Regional Segments  124

10.2.      Region   124

10.2.1.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Region, 2023 & 2032  124

10.2.2.  Semi Solid Dosage Forms Contract Manufacturing Market Attractiveness Analysis, By Region  125

10.2.3.  Incremental Revenue Growth Opportunity, by Region, 2024 – 2032  126

10.2.4.  Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018, 2023, 2027 & 2032  127

10.2.5.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 128

10.2.6.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 128

10.3.      Type  129

10.3.1.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 129

10.3.2.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 129

10.4.      Application   130

10.4.1.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 130

10.4.2.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 130

10.5.      Therapeutic Area  131

10.5.1.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 131

10.5.2.  Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 131

Chapter No. 11 :              Semi Solid Dosage Forms Contract Manufacturing Market – North America  132

11.1.      North America  132

11.2.      Key Highlights  133

11.2.1.  North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 134

11.2.2.  North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 135

11.2.3.  North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 136

11.2.4.  North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 137

11.2.5.  U.S. 138

11.2.5.1.              U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 138

11.2.5.2.              U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 139

11.2.5.3.              U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 140

11.2.6.  Canada  141

11.2.6.1.              Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 141

11.2.6.2.              Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 142

11.2.6.3.              Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 143

11.2.7.  Mexico   144

11.2.7.1.              Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 144

11.2.7.2.              Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 145

11.2.7.3.              Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 146

Chapter No. 12 :              Semi Solid Dosage Forms Contract Manufacturing Market – Europe  147

12.1.      Europe  147

12.2.      Key Highlights  148

12.2.1.  Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 149

12.2.2.  Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 151

12.2.3.  Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 152

12.2.4.  Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 153

12.2.5.  UK  154

12.2.5.1.              UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 154

12.2.5.2.              UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 155

12.2.5.3.              UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 156

12.2.6.  France  157

12.2.6.1.              UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 157

12.2.6.2.              France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 158

12.2.6.3.              France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 159

12.2.7.  Germany  160

12.2.7.1.              Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 160

12.2.7.2.              Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 161

12.2.7.3.              Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 162

12.2.8.  Italy  163

12.2.8.1.              Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 163

12.2.8.2.              Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 164

12.2.8.3.              Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 165

12.2.9.  Spain  166

12.2.9.1.              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 166

12.2.9.2.              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 167

12.2.9.3.              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 168

12.2.10.               Russia  169

12.2.10.1.            Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 169

12.2.10.2.            Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 170

12.2.10.3.            Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 171

12.2.11.               Belgium    172

12.2.11.1.            Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 172

12.2.11.2.            Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 173

12.2.11.3.            Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 174

12.2.12.               Netherland  175

12.2.12.1.            Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 175

12.2.12.2.            Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 176

12.2.12.3.            Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 177

12.2.13.               Austria  178

12.2.13.1.            Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 178

12.2.13.2.            Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 179

12.2.13.3.            Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 180

12.2.14.               Sweden  181

12.2.14.1.            Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 181

12.2.14.2.            Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 182

12.2.14.3.            Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 183

12.2.15.               Poland  184

12.2.15.1.            Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 184

12.2.15.2.            Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 185

12.2.15.3.            Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 186

12.2.16.               Denmark  187

12.2.16.1.            Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 187

12.2.16.2.            Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 188

12.2.16.3.            Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 189

12.2.17.               Switzerland  190

12.2.17.1.            Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 190

12.2.17.2.            Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 191

12.2.17.3.            Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 192

12.2.18.               Rest of Europe  193

12.2.18.1.            Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 193

12.2.18.2.            Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 194

12.2.18.3.            Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 195

Chapter No. 13 :              Semi Solid Dosage Forms Contract Manufacturing Market – Asia Pacific  196

13.1.      Asia Pacific  196

13.2.      Key Highlights  197

13.2.1.  Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 198

13.2.2.  Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 200

13.2.3.  Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 201

13.2.4.  Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 202

13.2.5.  China  203

13.2.5.1.              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 203

13.2.5.2.              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 204

13.2.5.3.              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 205

13.2.6.  Japan  206

13.2.6.1.              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 206

13.2.6.2.              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 207

13.2.6.3.              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 208

13.2.7.  South Korea  209

13.2.7.1.              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 209

13.2.7.2.              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 210

13.2.7.3.              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 211

13.2.8.  India  212

13.2.8.1.              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 212

13.2.8.2.              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 213

13.2.8.3.              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 214

13.2.9.  Australia  215

13.2.9.1.              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 215

13.2.9.2.              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 216

13.2.9.3.              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 217

13.2.10.               Thailand  218

13.2.10.1.            Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 218

13.2.10.2.            Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 219

13.2.10.3.            Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 220

13.2.11.               Indonesia  221

13.2.11.1.            Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 221

13.2.11.2.            Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 222

13.2.11.3.            Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 223

13.2.12.               Vietnam    224

13.2.12.1.            Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 224

13.2.12.2.            Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 225

13.2.12.3.            Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 226

13.2.13.               Malaysia  227

13.2.13.1.            Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 227

13.2.13.2.            Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 228

13.2.13.3.            Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 229

13.2.14.               Philippines  230

13.2.14.1.            Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 230

13.2.14.2.            Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 231

13.2.14.3.            Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 232

13.2.15.               Taiwan  233

13.2.15.1.            Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 233

13.2.15.2.            Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 234

13.2.15.3.            Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 235

13.2.16.               Rest of Asia Pacific  236

13.2.16.1.            Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 236

13.2.16.2.            Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 237

13.2.16.3.            Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 238

Chapter No. 14 :              Semi Solid Dosage Forms Contract Manufacturing Market – Latin America  239

14.1.      Latin America  239

14.2.      Key Highlights  240

14.2.1.  Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 241

14.2.2.  Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 242

14.2.3.  Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 243

14.2.4.  Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 244

14.2.5.  Brazil 245

14.2.5.1.              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 245

14.2.5.2.              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 246

14.2.5.3.              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 247

14.2.6.  Argentina  248

14.2.6.1.              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 248

14.2.6.2.              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 249

14.2.6.3.              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 250

14.2.7.  Peru  251

14.2.7.1.              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 251

14.2.7.2.              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 252

14.2.7.3.              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 253

14.2.8.  Chile  254

14.2.8.1.              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 254

14.2.8.2.              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 255

14.2.8.3.              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 256

14.2.9.  Colombia  257

14.2.9.1.              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 257

14.2.9.2.              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 258

14.2.9.3.              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 259

14.2.10.               Rest of Latin America  260

14.2.10.1.            Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 260

14.2.10.2.            Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 261

14.2.10.3.            Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 262

Chapter No. 15 :              Semi Solid Dosage Forms Contract Manufacturing Market – Middle East  263

15.1.      The Middle-East  263

15.2.      Key Highlights  264

15.2.1.  Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 265

15.2.2.  Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 266

15.2.3.  Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 267

15.2.4.  Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 268

15.2.5.  UAE  269

15.2.5.1.              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 269

15.2.5.2.              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 270

15.2.5.3.              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 271

15.2.6.  KSA   272

15.2.6.1.              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 272

15.2.6.2.              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 273

15.2.6.3.              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 274

15.2.7.  Israel 275

15.2.7.1.              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 275

15.2.7.2.              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 276

15.2.7.3.              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 277

15.2.8.  Turkey  278

15.2.8.1.              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 278

15.2.8.2.              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 279

15.2.8.3.              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 280

15.2.9.  Iran  281

15.2.9.1.              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 281

15.2.9.2.              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 282

15.2.9.3.              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 283

15.2.10.               Rest of Middle East & Africa  284

15.2.10.1.            Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 284

15.2.10.2.            Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 285

15.2.10.3.            Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 286

Chapter No. 16 :              Semi Solid Dosage Forms Contract Manufacturing Market – Africa  287

16.1.      Africa  287

16.2.      Key Highlights  288

16.2.1.  Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 289

16.2.2.  Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 290

16.2.3.  Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 291

16.2.4.  Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 292

16.2.5.  South Africa  293

16.2.5.1.              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 293

16.2.5.2.              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 294

16.2.5.3.              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 295

16.2.6.  Egypt  296

16.2.6.1.              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 296

16.2.6.2.              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 297

16.2.6.3.              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 298

16.2.7.  Nigeria  299

16.2.7.1.              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 299

16.2.7.2.              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 300

16.2.7.3.              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 301

16.2.8.  Algeria  302

16.2.8.1.              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 302

16.2.8.2.              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 303

16.2.8.3.              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 304

16.2.9.  Morocco   305

16.2.9.1.              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 305

16.2.9.2.              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 306

16.2.9.3.              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 307

16.2.10.               Rest of Africa  308

16.2.10.1.            Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 308

16.2.10.2.            Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 309

16.2.10.3.            Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 310

Chapter No. 17 :              Company Profiles  311

17.1.      AbbVie Inc. 311

17.1.1.  Company Overview   311

17.1.2.  Product Portfolio   312

17.1.3.  Financial Overview   312

17.2.      Aenova Group   313

17.2.1.  Company Overview   313

17.2.2.  Product Portfolio   314

17.2.3.  Financial Overview   314

17.3.      Catalent, Inc. 315

17.3.1.  Company Overview   315

17.3.2.  Product Portfolio   316

17.3.3.  Financial Overview   316

17.4.      Lonza  317

17.4.1.  Company Overview   317

17.4.2.  Product Portfolio   318

17.4.3.  Financial Overview   318

17.5.      Piramal Enterprises Ltd. 319

17.5.1.  Company Overview   319

17.5.2.  Product Portfolio   320

17.5.3.  Financial Overview   320

17.6.      Recipharm AB   321

17.6.1.  Company Overview   321

17.6.2.  Product Portfolio   322

17.6.2.1.              Financial Overview   322

17.7.      Thermo Fisher Scientific  323

17.7.1.  Company Overview   323

17.7.2.  Product Portfolio   324

17.7.3.  Financial Overview   324

17.8.      Almac Group   325

17.8.1.  Company Overview   325

17.8.2.  Product Portfolio   326

17.8.3.  Financial Overview   326

17.9.      Ascendia Pharmaceuticals  327

17.9.1.  Company Overview   327

17.9.2.  Product Portfolio   328

17.9.3.  Financial Overview   329

17.10.    Ciron Drugs & Pharmaceuticals Pvt. Ltd. 330

17.10.1.               Company Overview   330

17.10.2.               Product Portfolio   330

17.10.3.               Financial Overview   331

17.11.    Fareva  332

17.11.1.               Company Overview   332

17.11.2.               Product Portfolio   333

17.11.3.               Financial Overview   333

17.12.    Granules India Limited   334

17.12.1.               Company Overview   334

17.12.2.               Product Portfolio   335

17.12.3.               Financial Overview   335

17.13.    Medical Products Laboratories, Inc. 336

17.13.1.               Company Overview   336

17.13.2.               Product Portfolio   336

17.13.3.               Financial Overview   337

17.14.    NextPharma  338

17.14.1.               Company Overview   338

17.14.2.               Product Portfolio   339

17.14.3.               Financial Overview   339

17.15.    Pfizer CentreOne  340

17.15.1.               Company Overview   340

17.15.2.               Product Portfolio   340

17.15.3.               Financial Overview   341

Chapter No. 18 :              Research Methodology  342

18.1.      Research Methodology  342

18.2.      Phase I – Secondary Research   343

18.3.      Phase II – Data Modeling  343

18.3.1.  Company Share Analysis Model 344

18.3.2.  Revenue Based Modeling  344

18.4.      Phase III – Primary Research   345

18.5.      Research Limitations  346

18.5.1.  Assumptions  346

 

List of Figures

FIG NO. 1.           Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, 2018 – 2032 (USD Million) 49

FIG NO. 2.           Porter’s Five Forces Analysis for Global Semi Solid Dosage Forms Contract Manufacturing Market  59

FIG NO. 3.           Value Chain Analysis for Global Semi Solid Dosage Forms Contract Manufacturing Market  61

FIG NO. 4.           Company Share Analysis, 2023  62

FIG NO. 5.           Company Share Analysis, 2023  63

FIG NO. 6.           Company Share Analysis, 2023  64

FIG NO. 7.           Semi Solid Dosage Forms Contract Manufacturing Market – Company Revenue Market Share, 2023  65

FIG NO. 8.           Company Assessment Metrics  66

FIG NO. 9.           Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Type, 2023 & 2032  80

FIG NO. 10.         Market Attractiveness Analysis, By Type  81

FIG NO. 11.         Incremental Revenue Growth Opportunity by Type, 2024 – 2032  82

FIG NO. 12.         Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018, 2023, 2027 & 2032  83

FIG NO. 13.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Creams, Revenue (USD Million) 2018 – 2032  84

FIG NO. 14.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Ointments, Revenue (USD Million) 2018 – 2032  86

FIG NO. 15.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Pastes, Revenue (USD Million) 2018 – 2032  88

FIG NO. 16.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Gels, Revenue (USD Million) 2018 – 2032  90

FIG NO. 17.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032  92

FIG NO. 18.         Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Application, 2023 & 2032  95

FIG NO. 19.         Market Attractiveness Analysis, By Application  96

FIG NO. 20.         Incremental Revenue Growth Opportunity by Application, 2024 – 2032  97

FIG NO. 21.         Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018, 2023, 2027 & 2032  98

FIG NO. 22.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Drug Product Development, Revenue (USD Million) 2018 – 2032  99

FIG NO. 23.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Fill-Finish Product Manufacturing, Revenue (USD Million) 2018 – 2032  101

FIG NO. 24.         Global Semi Solid Dosage Forms Contract Manufacturing Market for API Manufacturing, Revenue (USD Million) 2018 – 2032  103

FIG NO. 25.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Packaging/Labelling, Revenue (USD Million) 2018 – 2032  105

FIG NO. 26.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032  107

FIG NO. 27.         Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Therapeutic Area, 2023 & 2032  110

FIG NO. 28.         Market Attractiveness Analysis, By Therapeutic Area  111

FIG NO. 29.         Incremental Revenue Growth Opportunity by Therapeutic Area, 2024 – 2032  112

FIG NO. 30.         Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018, 2023, 2027 & 2032  113

FIG NO. 31.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Dermatological Applications, Revenue (USD Million) 2018 – 2032  114

FIG NO. 32.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Topical Analgesics, Revenue (USD Million) 2018 – 2032  116

FIG NO. 33.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Skincare Products, Revenue (USD Million) 2018 – 2032  118

FIG NO. 34.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Wound Healing, Revenue (USD Million) 2018 – 2032  120

FIG NO. 35.         Global Semi Solid Dosage Forms Contract Manufacturing Market for Others, Revenue (USD Million) 2018 – 2032  122

FIG NO. 36.         Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue Share, By Region, 2023 & 2032  124

FIG NO. 37.         Market Attractiveness Analysis, By Region  125

FIG NO. 38.         Incremental Revenue Growth Opportunity by Region, 2024 – 2032  126

FIG NO. 39.         Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018, 2023, 2027 & 2032  127

FIG NO. 40.         North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, 2018 – 2032 (USD Million) 132

FIG NO. 41.         Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 147

FIG NO. 42.         Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 196

FIG NO. 43.         Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 239

FIG NO. 44.         The Middle-East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 263

FIG NO. 45.         Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, 2018 – 2023 (USD Million) 287

FIG NO. 46.         Research Methodology – Detailed View   342

FIG NO. 47.         Research Methodology  343

 

List of Tables

TABLE NO. 1. :    Global Semi Solid Dosage Forms Contract Manufacturing Market: Snapshot  48

TABLE NO. 2. :    Drivers for the Semi Solid Dosage Forms Contract Manufacturing Market: Impact Analysis  52

TABLE NO. 3. :    Restraints for the Semi Solid Dosage Forms Contract Manufacturing Market: Impact Analysis  55

TABLE NO. 4. :    Global Creams Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 85

TABLE NO. 5. :    Global Creams Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 85

TABLE NO. 6. :    Global Ointments Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 87

TABLE NO. 7. :    Global Ointments Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 87

TABLE NO. 8. :    Global Pastes Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 89

TABLE NO. 9. :    Global Pastes Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 89

TABLE NO. 10. : Global Gels Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 91

TABLE NO. 11. : Global Gels Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 91

TABLE NO. 12. : Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 93

TABLE NO. 13. : Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 93

TABLE NO. 14. : Global Drug Product Development Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 100

TABLE NO. 15. : Global Drug Product Development Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 100

TABLE NO. 16. : Global Fill-Finish Product Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 102

TABLE NO. 17. : Global Fill-Finish Product Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 102

TABLE NO. 18. : Global API Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 104

TABLE NO. 19. : Global API Manufacturing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 104

TABLE NO. 20. : Global Packaging/Labelling Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 106

TABLE NO. 21. : Global Packaging/Labelling Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 106

TABLE NO. 22. : Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 108

TABLE NO. 23. : Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 108

TABLE NO. 24. : Global Dermatological Applications Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 115

TABLE NO. 25. : Global Dermatological Applications Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 115

TABLE NO. 26. : Global Topical Analgesics Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 117

TABLE NO. 27. : Global Topical Analgesics Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 117

TABLE NO. 28. : Global Skincare Products Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 119

TABLE NO. 29. : Global Skincare Products Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 119

TABLE NO. 30. : Global Wound Healing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 121

TABLE NO. 31. : Global Wound Healing Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 121

TABLE NO. 32. : Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 123

TABLE NO. 33. : Global Others Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 123

TABLE NO. 34. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2018 – 2023 (USD Million) 128

TABLE NO. 35. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Region, 2024 – 2032 (USD Million) 128

TABLE NO. 36. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 129

TABLE NO. 37. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 129

TABLE NO. 38. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 130

TABLE NO. 39. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 130

TABLE NO. 40. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 131

TABLE NO. 41. : Global Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 131

TABLE NO. 42. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 134

TABLE NO. 43. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 134

TABLE NO. 44. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 135

TABLE NO. 45. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 135

TABLE NO. 46. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 136

TABLE NO. 47. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 136

TABLE NO. 48. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 137

TABLE NO. 49. : North America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 137

TABLE NO. 50. : U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 138

TABLE NO. 51. : U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 138

TABLE NO. 52. : U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 139

TABLE NO. 53. : U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 139

TABLE NO. 54. : U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 140

TABLE NO. 55. : U.S. Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 140

TABLE NO. 56. : Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 141

TABLE NO. 57. : Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 141

TABLE NO. 58. : Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 142

TABLE NO. 59. : Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 142

TABLE NO. 60. : Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 143

TABLE NO. 61. : Canada Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 143

TABLE NO. 62. : Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 144

TABLE NO. 63. : Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 144

TABLE NO. 64. : Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 145

TABLE NO. 65. : Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 145

TABLE NO. 66. : Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 146

TABLE NO. 67. : Mexico Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 146

TABLE NO. 68. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 149

TABLE NO. 69. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 150

TABLE NO. 70. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 151

TABLE NO. 71. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 151

TABLE NO. 72. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 152

TABLE NO. 73. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 152

TABLE NO. 74. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 153

TABLE NO. 75. : Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 153

TABLE NO. 76. : UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 154

TABLE NO. 77. : UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 154

TABLE NO. 78. : UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 155

TABLE NO. 79. : UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 155

TABLE NO. 80. : UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 156

TABLE NO. 81. : UK Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 156

TABLE NO. 82. : France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 157

TABLE NO. 83. : France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 157

TABLE NO. 84. : France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 158

TABLE NO. 85. : France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 158

TABLE NO. 86. : France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 159

TABLE NO. 87. : France Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 159

TABLE NO. 88. : Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 160

TABLE NO. 89. : Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 160

TABLE NO. 90. : Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 161

TABLE NO. 91. : Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 161

TABLE NO. 92. : Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 162

TABLE NO. 93. : Germany Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 162

TABLE NO. 94. : Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 163

TABLE NO. 95. : Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 163

TABLE NO. 96. : Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 164

TABLE NO. 97. : Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 164

TABLE NO. 98. : Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 165

TABLE NO. 99. : Italy Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 165

TABLE NO. 100. :              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 166

TABLE NO. 101. :              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 166

TABLE NO. 102. :              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 167

TABLE NO. 103. :              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 167

TABLE NO. 104. :              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 168

TABLE NO. 105. :              Spain Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 168

TABLE NO. 106. :              Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 169

TABLE NO. 107. :              Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 169

TABLE NO. 108. :              Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 170

TABLE NO. 109. :              Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 170

TABLE NO. 110. :              Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 171

TABLE NO. 111. :              Russia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 171

TABLE NO. 112. :              Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 172

TABLE NO. 113. :              Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 172

TABLE NO. 114. :              Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 173

TABLE NO. 115. :              Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 173

TABLE NO. 116. :              Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 174

TABLE NO. 117. :              Belgium Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 174

TABLE NO. 118. :              Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 175

TABLE NO. 119. :              Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 175

TABLE NO. 120. :              Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 176

TABLE NO. 121. :              Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 176

TABLE NO. 122. :              Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 177

TABLE NO. 123. :              Netherland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 177

TABLE NO. 124. :              Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 178

TABLE NO. 125. :              Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 178

TABLE NO. 126. :              Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 179

TABLE NO. 127. :              Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 179

TABLE NO. 128. :              Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 180

TABLE NO. 129. :              Austria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 180

TABLE NO. 130. :              Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 181

TABLE NO. 131. :              Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 181

TABLE NO. 132. :              Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 182

TABLE NO. 133. :              Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 182

TABLE NO. 134. :              Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 183

TABLE NO. 135. :              Sweden Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 183

TABLE NO. 136. :              Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 184

TABLE NO. 137. :              Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 184

TABLE NO. 138. :              Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 185

TABLE NO. 139. :              Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 185

TABLE NO. 140. :              Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 186

TABLE NO. 141. :              Poland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 186

TABLE NO. 142. :              Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 187

TABLE NO. 143. :              Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 187

TABLE NO. 144. :              Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 188

TABLE NO. 145. :              Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 188

TABLE NO. 146. :              Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 189

TABLE NO. 147. :              Denmark Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 189

TABLE NO. 148. :              Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 190

TABLE NO. 149. :              Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 190

TABLE NO. 150. :              Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 191

TABLE NO. 151. :              Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 191

TABLE NO. 152. :              Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 192

TABLE NO. 153. :              Switzerland Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 192

TABLE NO. 154. :              Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 193

TABLE NO. 155. :              Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 193

TABLE NO. 156. :              Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 194

TABLE NO. 157. :              Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 194

TABLE NO. 158. :              Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 195

TABLE NO. 159. :              Rest of Europe Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 195

TABLE NO. 160. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 198

TABLE NO. 161. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 199

TABLE NO. 162. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 200

TABLE NO. 163. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 200

TABLE NO. 164. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 201

TABLE NO. 165. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 201

TABLE NO. 166. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 202

TABLE NO. 167. :              Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 202

TABLE NO. 168. :              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 203

TABLE NO. 169. :              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 203

TABLE NO. 170. :              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 204

TABLE NO. 171. :              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 204

TABLE NO. 172. :              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 205

TABLE NO. 173. :              China Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 205

TABLE NO. 174. :              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 206

TABLE NO. 175. :              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 206

TABLE NO. 176. :              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 207

TABLE NO. 177. :              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 207

TABLE NO. 178. :              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 208

TABLE NO. 179. :              Japan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 208

TABLE NO. 180. :              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 209

TABLE NO. 181. :              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 209

TABLE NO. 182. :              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 210

TABLE NO. 183. :              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 210

TABLE NO. 184. :              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 211

TABLE NO. 185. :              South Korea Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 211

TABLE NO. 186. :              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 212

TABLE NO. 187. :              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 212

TABLE NO. 188. :              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 213

TABLE NO. 189. :              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 213

TABLE NO. 190. :              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 214

TABLE NO. 191. :              India Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 214

TABLE NO. 192. :              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 215

TABLE NO. 193. :              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 215

TABLE NO. 194. :              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 216

TABLE NO. 195. :              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 216

TABLE NO. 196. :              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 217

TABLE NO. 197. :              Australia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 217

TABLE NO. 198. :              Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 218

TABLE NO. 199. :              Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 218

TABLE NO. 200. :              Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 219

TABLE NO. 201. :              Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 219

TABLE NO. 202. :              Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 220

TABLE NO. 203. :              Thailand Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 220

TABLE NO. 204. :              Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 221

TABLE NO. 205. :              Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 221

TABLE NO. 206. :              Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 222

TABLE NO. 207. :              Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 222

TABLE NO. 208. :              Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 223

TABLE NO. 209. :              Indonesia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 223

TABLE NO. 210. :              Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 224

TABLE NO. 211. :              Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 224

TABLE NO. 212. :              Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 225

TABLE NO. 213. :              Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 225

TABLE NO. 214. :              Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 226

TABLE NO. 215. :              Vietnam Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 226

TABLE NO. 216. :              Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 227

TABLE NO. 217. :              Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 227

TABLE NO. 218. :              Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 228

TABLE NO. 219. :              Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 228

TABLE NO. 220. :              Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 229

TABLE NO. 221. :              Malaysia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 229

TABLE NO. 222. :              Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 230

TABLE NO. 223. :              Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 230

TABLE NO. 224. :              Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 231

TABLE NO. 225. :              Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 231

TABLE NO. 226. :              Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 232

TABLE NO. 227. :              Philippines Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 232

TABLE NO. 228. :              Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 233

TABLE NO. 229. :              Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 233

TABLE NO. 230. :              Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 234

TABLE NO. 231. :              Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 234

TABLE NO. 232. :              Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 235

TABLE NO. 233. :              Taiwan Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 235

TABLE NO. 234. :              Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 236

TABLE NO. 235. :              Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 236

TABLE NO. 236. :              Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 237

TABLE NO. 237. :              Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 237

TABLE NO. 238. :              Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 238

TABLE NO. 239. :              Rest of Asia Pacific Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 238

TABLE NO. 240. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 241

TABLE NO. 241. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 241

TABLE NO. 242. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 242

TABLE NO. 243. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 242

TABLE NO. 244. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 243

TABLE NO. 245. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 243

TABLE NO. 246. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 244

TABLE NO. 247. :              Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 244

TABLE NO. 248. :              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 245

TABLE NO. 249. :              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 245

TABLE NO. 250. :              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 246

TABLE NO. 251. :              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 246

TABLE NO. 252. :              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 247

TABLE NO. 253. :              Brazil Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 247

TABLE NO. 254. :              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 248

TABLE NO. 255. :              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 248

TABLE NO. 256. :              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 249

TABLE NO. 257. :              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 249

TABLE NO. 258. :              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 250

TABLE NO. 259. :              Argentina Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 250

TABLE NO. 260. :              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 251

TABLE NO. 261. :              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 251

TABLE NO. 262. :              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 252

TABLE NO. 263. :              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 252

TABLE NO. 264. :              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 253

TABLE NO. 265. :              Peru Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 253

TABLE NO. 266. :              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 254

TABLE NO. 267. :              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 254

TABLE NO. 268. :              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 255

TABLE NO. 269. :              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 255

TABLE NO. 270. :              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 256

TABLE NO. 271. :              Chile Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 256

TABLE NO. 272. :              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 257

TABLE NO. 273. :              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 257

TABLE NO. 274. :              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 258

TABLE NO. 275. :              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 258

TABLE NO. 276. :              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 259

TABLE NO. 277. :              Colombia Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 259

TABLE NO. 278. :              Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 260

TABLE NO. 279. :              Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 260

TABLE NO. 280. :              Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 261

TABLE NO. 281. :              Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 261

TABLE NO. 282. :              Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 262

TABLE NO. 283. :              Rest of Latin America Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 262

TABLE NO. 284. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 265

TABLE NO. 285. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 265

TABLE NO. 286. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 266

TABLE NO. 287. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 266

TABLE NO. 288. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 267

TABLE NO. 289. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 267

TABLE NO. 290. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 268

TABLE NO. 291. :              Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 268

TABLE NO. 292. :              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 269

TABLE NO. 293. :              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 269

TABLE NO. 294. :              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 270

TABLE NO. 295. :              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 270

TABLE NO. 296. :              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 271

TABLE NO. 297. :              UAE Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 271

TABLE NO. 298. :              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 272

TABLE NO. 299. :              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 272

TABLE NO. 300. :              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 273

TABLE NO. 301. :              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 273

TABLE NO. 302. :              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 274

TABLE NO. 303. :              KSA Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 274

TABLE NO. 304. :              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 275

TABLE NO. 305. :              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 275

TABLE NO. 306. :              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 276

TABLE NO. 307. :              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 276

TABLE NO. 308. :              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 277

TABLE NO. 309. :              Israel Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 277

TABLE NO. 310. :              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 278

TABLE NO. 311. :              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 278

TABLE NO. 312. :              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 279

TABLE NO. 313. :              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 279

TABLE NO. 314. :              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 280

TABLE NO. 315. :              Turkey Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 280

TABLE NO. 316. :              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 281

TABLE NO. 317. :              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 281

TABLE NO. 318. :              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 282

TABLE NO. 319. :              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 282

TABLE NO. 320. :              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 283

TABLE NO. 321. :              Iran Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 283

TABLE NO. 322. :              Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 284

TABLE NO. 323. :              Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 284

TABLE NO. 324. :              Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 285

TABLE NO. 325. :              Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 285

TABLE NO. 326. :              Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 286

TABLE NO. 327. :              Rest of Middle East Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 286

TABLE NO. 328. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2018 – 2023 (USD Million) 289

TABLE NO. 329. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Country, 2024 – 2032 (USD Million) 289

TABLE NO. 330. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 290

TABLE NO. 331. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 290

TABLE NO. 332. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 291

TABLE NO. 333. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 291

TABLE NO. 334. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 292

TABLE NO. 335. :              Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 292

TABLE NO. 336. :              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 293

TABLE NO. 337. :              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 293

TABLE NO. 338. :              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 294

TABLE NO. 339. :              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 294

TABLE NO. 340. :              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 295

TABLE NO. 341. :              South Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 295

TABLE NO. 342. :              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 296

TABLE NO. 343. :              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 296

TABLE NO. 344. :              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 297

TABLE NO. 345. :              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 297

TABLE NO. 346. :              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 298

TABLE NO. 347. :              Egypt Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 298

TABLE NO. 348. :              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 299

TABLE NO. 349. :              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 299

TABLE NO. 350. :              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 300

TABLE NO. 351. :              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 300

TABLE NO. 352. :              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 301

TABLE NO. 353. :              Nigeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 301

TABLE NO. 354. :              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 302

TABLE NO. 355. :              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 302

TABLE NO. 356. :              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 303

TABLE NO. 357. :              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 303

TABLE NO. 358. :              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 304

TABLE NO. 359. :              Algeria Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 304

TABLE NO. 360. :              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 305

TABLE NO. 361. :              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 305

TABLE NO. 362. :              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 306

TABLE NO. 363. :              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 306

TABLE NO. 364. :              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 307

TABLE NO. 365. :              Morocco Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 307

TABLE NO. 366. :              Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2018 – 2023 (USD Million) 308

TABLE NO. 367. :              Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Type, 2024 – 2032 (USD Million) 308

TABLE NO. 368. :              Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2018 – 2023 (USD Million) 309

TABLE NO. 369. :              Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Application, 2024 – 2032 (USD Million) 309

TABLE NO. 370. :              Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2018 – 2023 (USD Million) 310

TABLE NO. 371. :              Rest of Africa Semi Solid Dosage Forms Contract Manufacturing Market Revenue, By Therapeutic Area, 2024 – 2032 (USD Million) 310

Frequently Asked Questions:

What are the key growth drivers fueling expansion in the semi-solid dosage forms contract manufacturing market?

The main drivers spurring growth in this market include the increasing demand for specialized formulations like creams, gels, and ointments that are easier to administer and have better efficacy and compliance. Additionally, the need for pharmaceutical companies to reduce costs through outsourced manufacturing and leverage CMOs’ expertise is expanding the market.

What was the global market value for semi-solid dosage form contract manufacturing in 2023?

The global demand for semi-solid dosage form contract manufacturing was valued at USD 13,569.19 million in 2023. This reflects the rapidly rising demand for outsourced manufacturing of specialized semi-solid formulations.

What is the expected market value in 2032 and compound annual growth rate between 2024-2032?

The market is projected to reach USD 21,913.76 million in 2032, exhibiting a CAGR of 5.40% over the period 2024-2032. This positive growth trajectory highlights the continued expansion expected in outsourced manufacturing of creams, gels and other semi-solid forms.

How does partnering with a contract manufacturing organization benefit pharmaceutical companies?

Strategic collaboration between pharma firms and CMOs enables efficient production of semi-solid dosage forms. Key benefits for pharma companies include faster market entry of new drugs, optimization of formulations, navigating regulatory landscapes, and accessing advanced manufacturing technologies/expertise in formulation development.

Cosmetic Ingredients Market

Published:
Report ID: 3703

Hydrocolloids Market

Published:
Report ID: 36265

Ion Exchange Resins Market

Published:
Report ID: 36220

Herbal Extract Market

Published:
Report ID: 36211

Fiber Reinforced Polymer (FRP) Composites Market

Published:
Report ID: 36197

Bio-based Polycarbonate Market

Published:
Report ID: 36188

Middle East and Africa Carbon Black Market

Published:
Report ID: 36181

India Thermic Fluids Market

Published:
Report ID: 36178

Europe Green Hydrogen Market

Published:
Report ID: 36175

Dodecanedioic Acid Market

Published:
Report ID: 36167

Asia Pacific Nickel Mining Market

Published:
Report ID: 36084

Asphalt Additives Market

Published:
Report ID: 36074

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN